Associations Between Plasma Adiponectin Concentrations and Liver Histology in Patients with Nonalcoholic Fatty Liver Disease.
From: Division of Internal Medicine, Sacro Cuore Hospital, Negrar, Italy. targher@sacrocuore.it
Clinical endocrinology
- Publish Date: Jun 2006
- ISSN: 0300-0664
- Volume: 64
- Issue: 6
- Pages: 679-83
- Medium: Print
- Language: English
- Citation (JAMA): Targher Giovanni, Bertolini Lorenzo, Rodella Stefano, et al. Associations Between Plasma Adiponectin Concentrations and Liver Histology in Patients with Nonalcoholic Fatty Liver Disease.. Clin. Endocrinol. (Oxf) Jun 2006;64:679-83
Abstract
OBJECTIVES: To explore associations between plasma adiponectin concentrations and liver histology in patients with nonalcoholic fatty liver disease (NAFLD). DESIGN AND PATIENTS: In a cross-sectional study, we enrolled 60 consecutive NAFLD patients and 60 age-, sex- and body mass index (BMI)-matched healthy controls. MEASUREMENTS: NAFLD (by liver biopsy), plasma adiponectin concentrations, insulin resistance (by homeostasis model assessment, HOMA-IR) and metabolic syndrome (MetS) features. RESULTS: NAFLD patients had a marked decrease in plasma adiponectin concentration (6.1 +/- 2.8 vs. 13.6 +/- 3.8 microg/ml, P < 0.001) compared with matched controls. MetS, as defined by the Adult Treatment Panel III (ATP III) criteria, and its individual components were more frequent among NAFLD patients. The marked differences in adiponectin concentrations that were observed between the groups were little affected by adjustment for age, sex, BMI, HOMA-IR score and MetS components. Notably, decreased adiponectin levels were closely associated with the degree of hepatic steatosis, necroinflammation and fibrosis (P < 0.001 for all) among NAFLD patients. By logistic regression analysis, low adiponectin levels independently predicted hepatic steatosis [odds ratio (OR) 2.3, 95% confidence interval (CI) 1.5-5.8, P < 0.001] and necroinflammation (OR 3.1, 95% CI 1.9-7, P < 0.001), but not fibrosis (P = 0.07), after adjustment for age, sex, BMI, HOMA-IR and MetS components. CONCLUSIONS: NAFLD patients have markedly lower plasma adiponectin concentrations than control subjects. Low adiponectin levels are strongly associated with the severity of liver histology, thus further supporting the hypothesis that adiponectin might be involved in the development of NAFLD.
Mesh Headings (Keywords): Adiponectin, Biological Markers, Blood Glucose, Epidemiologic Methods, Fatty Liver, Female, Humans, Insulin, Liver, Liver Function Tests, Male, Middle Aged, Triglycerides
Check for Full Text / PubMed Unique Identifier (PMID): 16712671
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.